Current position of beta-adrenoblockers in coronary heart disease management: information for clinicians

Abstract

Beta-adrenoblockers (ВАВ) are widely used in coronary heart disease (CHD) management. The choice of specific ВАВ and their place in optimal schemes for CHD treatment are discussed.

Keywords

• coronary heart disease
• beta-adrenoblockers
• antiarrhythmic effect